Indaptus Therapeutics, Inc. financial data

Symbol
INDP on Nasdaq
Industry
Pharmaceutical Preparations
Location
3 Columbus Circle, 15 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Intec Parent Inc. (to 8/3/2021)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 565 % -41.5%
Debt-to-equity 20.6 % +80.7%
Return On Equity -147 % -131%
Return On Assets -122 % -113%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.2M shares +21.4%
Common Stock, Shares, Outstanding 8.55M shares +1.81%
Entity Public Float 13.3M USD -11.9%
Common Stock, Value, Issued 85.5K USD +1.81%
Weighted Average Number of Shares Outstanding, Basic 8.54M shares +1.7%
Weighted Average Number of Shares Outstanding, Diluted 8.54M shares +1.7%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.57M USD +9.95%
General and Administrative Expense 8.91M USD +2.36%
Operating Income (Loss) -16.5M USD -5.71%
Nonoperating Income (Expense) 733K USD -24.4%
Net Income (Loss) Attributable to Parent -15.7M USD -7.71%
Earnings Per Share, Basic -1.85 USD/shares -5.11%
Earnings Per Share, Diluted -1.85 USD/shares -20.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.3M USD -42.5%
Marketable Securities, Current 6.99M USD -62.7%
Assets, Current 7.49M USD -62.3%
Property, Plant and Equipment, Net 735 USD -63.6%
Operating Lease, Right-of-Use Asset 129K USD -40.4%
Other Assets, Noncurrent 505K USD -33.1%
Assets 8.12M USD -61%
Accounts Payable, Current 417K USD -44.3%
Employee-related Liabilities, Current 679K USD +26.1%
Liabilities, Current 1.93M USD -8.32%
Operating Lease, Liability, Noncurrent 27.6K USD -76.3%
Liabilities 1.96M USD -11.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 134K USD
Retained Earnings (Accumulated Deficit) -53.2M USD -42%
Stockholders' Equity Attributable to Parent 6.17M USD -66.9%
Liabilities and Equity 8.12M USD -61%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.94M USD +20.7%
Net Cash Provided by (Used in) Financing Activities 316K USD
Net Cash Provided by (Used in) Investing Activities 2.14M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 8.55M shares +1.81%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Deferred Tax Assets, Valuation Allowance 54.5M USD +4.83%
Deferred Tax Assets, Gross 54.5M USD +4.86%
Operating Lease, Liability 131K USD -39.6%
Depreciation 735 USD +129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.9M USD -9.83%
Lessee, Operating Lease, Liability, to be Paid 138K USD -42.1%
Operating Lease, Liability, Current 103K USD +2.79%
Lessee, Operating Lease, Liability, to be Paid, Year Two 86.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 86.9K USD -14.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.17K USD -67.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 86.9K USD
Deferred Tax Assets, Operating Loss Carryforwards 51.8M USD +3.19%
Operating Lease, Payments 25.3K USD +2.36%
Additional Paid in Capital 59.3M USD +6.12%
Share-based Payment Arrangement, Expense 2.32M USD +3965%